EHL BIO, a bio company leading stem cell and immune cell treatment, is the first in Korea to receive approval for human cell management and cell processing facilities certified by the Ministry of Food and Drug Safety.
Stem cell therapy for liver cirrhosis, diabetes, male sexual dysfunction (e.g., erectile dysfunction), autoimmune diseases, Parkinson's disease, degenerative arthritis, myocardial infarction, chronic obstructive pulmonary disease, etc., and immune cell data for various cancers such as lung cancer and liver cancer If you have any questions, please contact the EHL Bio website (ehlbio.co.kr) Support.